CDK8 regulates E2F1 transcriptional activity through S375 phosphorylation

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Oncogene

• Publication date

  2013-07-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/onc.2012.364PMID 22945643
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dysregulation of CDK8 and Cyclin C in tumorigenesis.

  2011cited by this paper
• E2F1 suppresses Wnt/β-catenin activity through transactivation of β-catenin interacting protein ICAT

  2011cited by this paper
• CDK8 is a positive regulator of transcriptional elongation within the serum response network

  2010cited by this paper
• CDK8 expression in 470 colorectal cancers in relation to β‐catenin activation, other molecular alterations and patient survival

  2010cited by this paper
• The histone variant macroH2A suppresses melanoma progression through regulation of CDK8

  2010cited by this paper
• Cell cycle deregulation in cancer

  2010cited by this paper
• Interplay Between Cyclin-Dependent Kinases and E2F-Dependent Transcription

  2010cited by this paper
• Cdk5 Suppresses the Neuronal Cell Cycle by Disrupting the E2F1–DP1 Complex

  2010cited by this paper
• CDK8: a positive regulator of transcription.

  2010cited by this paper
• The human Mediator complex: a versatile, genome-wide regulator of transcription.

  2010cited by this paper
• The human CDK8 subcomplex is a molecular switch that controls Mediator coactivator function.

  2009cited by this paper
• Aurora B kinase regulates the postmitotic endoreduplication checkpoint via phosphorylation of the retinoblastoma protein at serine 780.

  2009cited by this paper
• Genetic prognostic and predictive markers in colorectal cancer

  2009cited by this paper
• Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling.

  2009cited by this paper
• Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways.

  2009cited by this paper
• Revving the Throttle on an oncogene: CDK8 takes the driver seat.

  2009cited by this paper
• Cooperative activity of cdk8 and GCN5L within Mediator directs tandem phosphoacetylation of histone H3

  2008cited by this paper
• E2F1 represses β-catenin transcription and is antagonized by both pRB and CDK8

  2008cited by this paper
• CDK8 is a colorectal cancer oncogene that regulates β-catenin activity

  2008cited by this paper
• The Human CDK8 Subcomplex Is a Histone Kinase That Requires Med12 for Activity and Can Function Independently of Mediator

  2008cited by this paper
• A quantitative atlas of mitotic phosphorylation

  2008cited by this paper
• CDK8 is a stimulus-specific positive coregulator of p53 target genes.

  2007cited by this paper
• Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome.

  2006cited by this paper
• Wnt Signaling: Multiple Pathways, Multiple Receptors, and Multiple Transcription Factors*

  2006cited by this paper
• Mediator Is a Transducer of Wnt/β-Catenin Signaling*

  2006cited by this paper
• Wnt/beta-catenin signaling in development and disease.

  2006cited by this paper
• Mediator is a transducer of Wnt/beta-catenin signaling.

  2006cited by this paper
• The AKT/IκB kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclear factor-κB and β-catenin

  2005cited by this paper
• The AKT/I kappa B kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclear factor-kappa B and beta-catenin.

  2005cited by this paper
• Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover.

  2004cited by this paper
• WNT and β-catenin signalling: diseases and therapies

  2004cited by this paper
• WNT and beta-catenin signalling: diseases and therapies.

  2004cited by this paper
• Evolving intricacies and implications of E2F1 regulation

  2003cited by this paper
• Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells.

  2003cited by this paper
• The RNA polymerase II machinery: structure illuminates function.

  2002cited by this paper
• The crystal structure of the beta-catenin/ICAT complex reveals the inhibitory mechanism of ICAT.

  2002cited by this paper
• Inhibition of Wnt signaling by ICAT, a novel β-catenin-interacting protein

  2000cited by this paper
• Inhibition of Wnt signaling by ICAT, a novel beta-catenin-interacting protein.

  2000cited by this paper
• Cyclin C/CDK8 and cyclin H/CDK7/p36 are biochemically distinct CTD kinases

  1999cited by this paper
• Residues phosphorylated by TFIIH are required for E2F‐1 degradation during S‐phase

  1999cited by this paper
• Regulation of cell proliferation by the E2F transcription factors.

  1998cited by this paper
• pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes.

  1997cited by this paper
• Phosphorylation of a specific cdk site in E2F-1 affects its electrophoretic mobility and promotes pRB-binding in vitro.

  1995cited by this paper
• Functional properties of a Drosophila homolog of the E2F1 gene

  1994cited by this paper
• Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation

  1994cited by this paper
• Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase.

  1994cited by this paper
• Functional synergy between DP‐1 and E2F‐1 in the cell cycle‐regulating transcription factor DRTF1/E2F.

  1993cited by this paper

• CDK8 Inhibition Increases E2F1 Transcriptional Activity and Promotes STAT3-Dependent Suppression of Mcl-1 in Triple-Negative Breast Cancer Cell Line MDA-MB-468

  2026cites this paper
• E2f1 Overexpression Reduces Aging-Associated DNA Damage in Cultured Cerebral Endothelial Cells and Improves Cognitive Performance in Aged Mice

  2025cites this paper
• Transcriptional coupling of telomeric retrotransposons with the cell cycle

  2025cites this paper
• Mediator Kinase Inhibitor Selectivity and Activity in Colorectal Cancer

  2025cites this paper
• A comprehensive description of cyclin-dependent kinase 8 (CDK8) inhibitors as anticancer agents.

  2025cites this paper
• Cyclin-dependent protein kinases and cell cycle regulation in biology and disease

  2025cites this paper
• Transcriptional cyclin-dependent kinases Cdk8 and Cdk19 are required for normal macrophage differentiation

  2025cites this paper
• Application of electrochemical sensors to analyze CDK8 promotes gastric cancer progression by transcriptional targeting MMP15 and NES

  2025cites this paper
• Design and synthesis of a 1,3,6-trimethyl-1H-benzo[d]imidazole-5-sulfonamide derivative as a type I CDK8 inhibitor against colorectal cancer.

  2025cites this paper
• Distinct effects of CDK8 module subunits on cellular growth and proliferation in Drosophila

  2024cites this paper
• Posttranslational modifications of E2F family members in the physiological state and in cancer: Roles, mechanisms and therapeutic targets.

  2024cites this paper
• Distinct effects of CDK8 module subunits on cellular growth and proliferation in Drosophila.

  2024cites this paper
• The study of a novel CDK8 inhibitor E966-0530-45418 that inhibits prostate cancer metastasis in vitro and in vivo.

  2023cites this paper
• MEKs/ERKs-mediated FBXO1/E2Fs interaction interference modulates G_1/S cell cycle transition and cancer cell proliferation

  2023cites this paper
• Transcriptional coupling of telomeric retrotransposons with the cell cycle

  2023cites this paper
• PP2A and its adapter protein IER5 induce the DNA-binding ability and target gene expression of E2F1 via dephosphorylation at serine 375.

  2023cites this paper
• CDK8 mediates coelomocyte proliferation via promoting β-catenin nuclear translocation in Vibrio splendidus-challenged Apostichopus japonicus

  2023cites this paper
• Knockout of ICAT in Adipose Tissue Alleviates Fibro-inflammation in Obese Mice

  2022cites this paper
• Investigation of CDK8 inhibitor Q-12 effects on CDK8 and CDK8 substrates in triple negative breast cancer cell line MDA-MB-468

  2022cites this paper
• A Selective and Orally Bioavailable Quinoline-6-Carbonitrile-Based Inhibitor of CDK8/19 Mediator Kinase with Tumor-Enriched Pharmacokinetics.

  2022cites this paper
• Targeting transcription cycles in cancer

  2021cites this paper
• Transcriptional cyclin-dependent kinases: Potential drug targets in cancer therapy.

  2021cites this paper
• Cdk8 Kinase Module: A Mediator of Life and Death Decisions in Times of Stress

  2021cites this paper
• Gene Transcription as a Therapeutic Target in Leukemia

  2021cites this paper
• Interplay between cofactors and transcription factors in hematopoiesis and hematological malignancies

  2021cites this paper
• CDKs family -a glimpse into the past and present: from cell cycle control to current biological functions

  2020cites this paper
• The Mediator CDK8-Cyclin C complex modulates Dpp signaling in Drosophila by stimulating Mad-dependent transcription

  2020influential citation
• Pharmacological Inhibition of CDK8 in Triple-Negative Breast Cancer Cell Line MDA-MB-468 Increases E2F1 Protein, Induces Phosphorylation of STAT3 and Apoptosis

  2020influential citation
• Mediator's Kinase Module: A Modular Regulator of Cell Fate

  2020cites this paper
• Regulation of E2F1 activity via PKA-mediated phosphorylations

  2020influential citation
• All-Atomic Molecular Dynamic Studies of Human and Drosophila CDK8: Insights into Their Kinase Domains, the LXXLL Motifs, and Drug Binding Site

  2020cites this paper
• Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer

  2020cites this paper
• Antagonizing CDK8 Sensitizes Colorectal Cancer to Radiation Through Potentiating the Transcription of e2f1 Target Gene apaf1

  2020influential citation
• Binding patterns and structure-activity relationship of CDK8 inhibitors.

  2020cites this paper
• Angel or Devil ? - CDK8 as the new drug target.

  2020cites this paper
• Cyclin C: The Story of a Non-Cycling Cyclin

  2019cites this paper
• Understanding Obesity as a Risk Factor for Uterine Tumors Using Drosophila.

  2019cites this paper
• Mediator function in plant metabolism revealed by large-scale biology.

  2019cites this paper
• The Role of Zyxin and LIMD1 in Mitosis and Cancer

  2019cites this paper
• CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors.

  2019cites this paper
• The Drosophila Model in Cancer

  2019cites this paper
• Investigations on Cancer Cell Biological Effects of CDK8 Inhibitor Q-12

  2018cites this paper
• CDK8/19 inhibition induces premature G1/S transition and ATR-dependent cell death in prostate cancer cells

  2018cites this paper
• Structure and Functions of the Mediator Complex

  2018cites this paper
• Control of Muscle Metabolism by the Mediator Complex.

  2018cites this paper
• Cyclin-Dependent Kinase 8: A New Hope in Targeted Cancer Therapy?

  2018cites this paper
• Zyxin promotes colon cancer tumorigenesis in a mitotic phosphorylation-dependent manner and through CDK8-mediated YAP activation

  2018cites this paper
• MicroRNA-770 affects proliferation and cell cycle transition by directly targeting CDK8 in glioma

  2018cites this paper
• CDK 8 as a therapeutic target for cancers and recent developments in discovery of CDK 8 inhibitors

  2018cites this paper
• The Mediator CDK8-Cyclin C complex modulates vein patterning in Drosophila by stimulating Mad-dependent transcription

  2018influential citation
• The Role Of Cdk8 In Metastatic Growth Of Colon Cancer

  2018cites this paper
• Design and synthesis of selective CDK8/19 dual inhibitors: Discovery of 4,5-dihydrothieno[3',4':3,4]benzo[1,2-d]isothiazole derivatives.

  2017cites this paper
• Aberrant expression of CDK8 regulates the malignant phenotype and associated with poor prognosis in human laryngeal squamous cell carcinoma

  2017cites this paper
• Derivation of the human cell cycle transcriptional signature

  2017cites this paper
• The role of retroviral cyclin in the development of walleye dermal sarcoma

  2017cites this paper
• signaling pathway and CDK8 in HCT signaling pathway and CDK8 in HCT signaling pathway and CDK8 in HCT 116 and

  2017cites this paper
• Inhibitors of cyclin‐dependent kinases as cancer therapeutics

  2017cites this paper
• CDK8/19 Mediator kinases potentiate induction of transcription by NFκB

  2017cites this paper
• The Mediator Complex: At the Nexus of RNA Polymerase II Transcription.

  2017cites this paper
• SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains

  2017cites this paper
• Regulation of metabolism by the Mediator complex

  2016cites this paper
• A MED13-dependent skeletal muscle gene program controls systemic glucose homeostasis and hepatic metabolism

  2016cites this paper
• Structure-Based Optimization of Potent, Selective, and Orally Bioavailable CDK8 Inhibitors Discovered by High-Throughput Screening.

  2016cites this paper
• Assessing the mechanism and therapeutic potential of modulators of the human Mediator complex-associated protein kinases

  2016influential citation
• The Mediator complex: a central integrator of transcription

  2015cites this paper
• Retroviral Cyclin Controls Cyclin-Dependent Kinase 8-Mediated Transcription Elongation and Reinitiation

  2015cites this paper
• Ellagic acid regulates Wnt/β-catenin signaling pathway and CDK8 in HCT 116 and HT 29 colon cancer cells

  2015cites this paper
• Cdk8 deletion in the ApcMin murine tumour model represses EZH2 activity and accelerates tumourigenesis

  2015cites this paper
• CDK8 kinase--An emerging target in targeted cancer therapy.

  2015cites this paper
• Comparative proteomic analysis of compartmentalised Ras signalling

  2015cites this paper
• Downregulation of CDK-8 inhibits colon cancer hepatic metastasis by regulating Wnt/β-catenin pathway.

  2015influential citation
• MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8

  2015cites this paper
• Characterization of a Novel Inhibitor and Substrates of the Mediator Kinases CDK8 and CDK19

  2015cites this paper
• Mediator and cell cycle regulation

  2015cites this paper
• Inhibiteurs thérapeutiques de cdk8 et utilisations de ceux-ci

  2014cites this paper
• Wogonin induced G1 cell cycle arrest by regulating Wnt/β-catenin signaling pathway and inactivating CDK8 in human colorectal cancer carcinoma cells.

  2013cites this paper
• Tumor-suppressive effects of CDK8 in endometrial cancer cells

  2013cites this paper
• The Mediator complex and transcription regulation

  2013cites this paper
• The Role of an Oncoprotein CIP2A in Breast Cancer

  2013cites this paper
• Emerging roles of Cdk8 in cell cycle control.

  2013cites this paper